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New trends and challenges in the development
of microfabricated probes for recording
and stimulating of excitable cells
Dries Braeken and Dimiter Prodanov
Bioelectronic Systems, IMEC vzw, Kapeldreef 75, 3001 Leuven
Belgium
I. Methods for the Recording of Electrical Signals from Cells in vitro and in vivo
1. Methods for the Recording of Electrical Activity from Cells In Vitro
1.1 Introduction
Excitable cells such as nerve cells communicate via signals transferred under the form of elec-
trical potentials, the so-called action potentials. The communication is transmitted from one
cell to another via numerous interconnections called synapses. This communication is critical
for the life of higher organisms. Electrical activity of these cells can be studied using primary
cell cultures, immortalized cell lines and acute slice preparations that are mostly brought in
contact with a surface for adhesion or growth promotion. The study of single or groups of
cells in these preparations is called ‘in vitro’ research. The study of the conduction of this
electrical activity ‘in vitro’ and its impairment is of great importance in the development of
new therapies for various neurological disorders such as Alzheimer’s and Parkinson’s disease,
and epilepsia. Methods for studying action potentials can be conducted outside (extracellular
recordings) or inside the cell (intracellular recordings).
The recording of the intracellular membrane potential requires either impaling the cell mem-
brane with a sharp glass micro-electrode or establishing electrical access to the cell with a
glass patch pipette. Extracellular recordings use either fixed or movable glass or insulated
metal/metaloxide electrodes, positioned on the outside of the cell. In the following, a brief
historical overview of the development of these techniques will be given, and new techniques
based on micro-fabrication that gained a growing attention recently will be discussed.
The recording of the intracellular membrane potential provides the most precise description
of the electrical behavior of a cell and, therefore, it requires specialized techniques. The use of
sharp glass micro-electrodes for intracellular recordings is a challenging method and mostly
limited to recordings in large cells from invertebrates. By impaling the cell with the sharp tip
of the glass pipette, holding a Ag/AgCl electrode connected to a voltage follower, changes in
the intracellular membrane potential can be measured. In addition, the pipette is usually filled
with a high concentrated salt solution (KCl) to decrease the electrical resistance. The first stud-
ies on action potentials were performed on neurons of invertebrates using these intracellular
glass micro-electrodes (Hodgkin (1939)).
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1.2 Extracellular Recording
Although intracellular recordings provide the measurement of the intracellular potential of a
cell, they are in any case invasive to the cell and its membrane. These recordings are, there-
fore, always limited in time. This rules out some investigations of important communication
processes, such as late phase long-term potentiation (LTP) recordings. Potential changes of the
membrane of a cell can also be measured from the outside of the membrane without making
any physical contact to the cell. Glass micro-electrodes or thin, insulated metal electrodes can
be used for extracellular recording of the membrane potential. Ionic movements across cell
membranes are detected by placing a recording electrode close to the cell. The extracellular
signal recorded upon the firing of an action potential is characterized by a brief, alternating
voltage between the recording electrode and a ground electrode. Extracellular recordings with
a glass electrode are thus advantageous in the investigation of long-term processes, such as
LTP. Because the electrode is in close proximity but not in direct contact with the cell, the
recordings are usually stable and not liable to mechanical instabilities. Although activity can
be detected at the level of a single cell, recordings usually reflect the averaged response of a
population of cells.
Despite the non-invasiveness of this method, the throughput of this type of experiments is
rather low. The researcher has to manually bring the electrodes close to the cell membrane to
be able to perform the recordings. With the progress in micro-fabrication techniques, planar
micro-electrodes were developed that were able to record extracellularly from cultured cells
grown on top of the electrode area. Planar micro-electrodes have been used as substrates for
the culture support and non-invasive recording of cells, and electrical activity of single cells
and networks of cells have been monitored successfully. In 1972, Thomas et al. described
the first attempt to record electrical activity from cultured cells using a micro-electrode array
(MEA) (Thomas et al. (1972)). They used gold-plated nickel electrodes on a glass substrate
passivated with patterned photoresist. Embryonic chick heart cells were cultured in a glass
chamber. Electrical activity was recorded extracellularly from the contracting heart cells si-
multaneously from many electrodes. Gross et al. used a similar system to record extracellular
electrical responses from explanted neural tissue from the snail Helix pomatia (Gross et al.
(1977)). Pine et al. were the first to report electrical recordings of dissociated neurons (supe-
rior cervical ganglia of neonatal rats) (Pine (1980)). Moreover, they combined the traditional
method of intracellular recording using a glass micro-pipette with extracellular recording us-
ing a metal micro-electrode. Combining both techniques enables validation and calibration
of the extracellular micro-electrode recording with the vast amount of information from in-
tracellular recordings. These successes led to many groups using planar micro-electrodes for
cultured cells (Droge et al. (1986); Eggers et al. (1990); Gross (1979); Gross et al. (1977); Marti-
noia et al. (1993); Novak & Wheeler (1986); Pine (1980); Thomas et al. (1972)).
The simultaneous stimulation and recording of cells is a logical next step and several re-
searchers have already succeeded in stimulation and recording of embryonic chick myocytes
cultured on planar micro-electrode arrays (Connolly et al. (1990); Israel et al. (1984)). In 1992,
Jimbo and Kawana further expanded the possibilities with these systems by stimulation of
neurites that were guided by micro-channels (Jimbo & Kawana (1992)). The same group later
reported the simultaneous recording of electrical activity and intracellular [Ca2+] using fluo-
rescent dyes, showing the combination of optical and electrical techniques (Jimbo et al. (1993)).
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1.3 Active Multitransistor Arrays
Although micro-electrode arrays are of growing interest in electrophysiological and pharma-
cological research, there are still shortcomings in these devices. The most abundant disad-
vantages are the low signal quality and the small amount of electrodes on the chip, which
are both technological aspects. Most micro-electrode arrays are passive arrays that only am-
plify the signal once it is led through wires connecting the electrodes. The capacitive load that
is introduced in this way attenuates the signal significantly. The small amount of electrodes
is based on the used micro-fabrication technology used in these systems. Technological im-
provements over the years, however, made it possible to address these shortcomings. In 1991,
Fromherz et al. reported recordings of extracellular field potentials from Retzius cells from
the leech Hirundo medicinalis measured by an integrated transistor (Fromherz et al. (1991)).
Here, the neuron was directly coupled to the gate of a field effect transistor that consisted of
silicon dioxide. The validation of the measured potentials was performed by injecting a micro-
electrode, which both stimulated the cell and monitored the intracellular voltage. Fromherz et
al. used this system to further investigate the physics behind the coupling of the neuron and
the transistor using an array of transistors below the neuron, as well as the capacitive stimu-
lation of the neuron through the oxide layer (Fromherz et al. (1993); Fromherz & Stett (1995)).
Recently, the same group showed the possibility of capacitive stimulation of specific ion chan-
nels using field effect transistors and recombinant HEK293 cells (Kupper et al. (2002)). In
general, dense arrays of transistors, called multi-transistor arrays, have been used in increas-
ing frequency for the recording of electrical activity from different cell types (Ingebrandt et al.
(2001); Kind et al. (2002); Lorenzelli et al. (2003); Martinoia & Massobrio (2004); Martinoia et al.
(2001); Meyburg et al. (2006)).
1.3.1 Cell-Chip Coupling
While these sensors show high signal-to-noise ratios, integration of read-out functionality and
the possibility for downscaling, which makes these systems superior to passive MEA systems,
this technology is still in an experimental phase and, therefore, very expensive. Furthermore,
another crucial design and fabrication problem is the need for a biocompatible system. Most
materials that are typically used in integrated circuitries are not optimized for use in liquids
and with cultured cells. Both MEAs and arrays of FETs have been mostly used for recording
from acute slices and large cells from invertebrates. Although some examples of extracellular
recordings of mammalian cells have been demonstrated, single-cell addressability of small,
mammalian cells remains challenging.
1.3.2 Recent Advances in Multitransistor Arrays
The electrical coupling between the cell membrane and the chip is mainly based on the contact
between the lipid bilayer and the surface of the chip and the most important factor responsible
for signal strength attenuation. Parameters that influence the cell-chip coupling are the dis-
tance between cell membrane and electrode and the electrical resistance that exists in this gap.
The distance between the cell membrane and the surface was characterized extensively by
Braun et al., using fluorescent dye molecules to stain the membrane on silicon chips with mi-
croscopic oxide terraces (Braun & Fromherz (2004)). Using HEK293 cells on chips coated with
fibronectin, the measured distance was ∼70 nm, independent of the electrical resistivity of the
bath (Gleixner & Fromherz (2006)). Later, the same group used fluorescence interference con-
trast microscopy to calculate the distance between the cell membrane and chip surface. The
separation between membrane and surface is caused by proteins in the membrane (glycoca-
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lyx) and the surface coating on the chip. This gap could be narrowed down to 20 nm, when
snail neurons were used on a laminin fragment that was anchored to the surface (Schoen &
Fromherz (2007)). The electrical coupling between the chip surface and the cell depends on the
electrical resistance of this thin layer between the oxide and the lipid bilayer. Fromherz et al.
used a technique with alternating voltages applied to the chip to map this electrical resistance.
The resistance and the capacitances of the surface (metal oxide) and membrane determine the
voltage across the attached membrane. In normal culture medium, the sheet resistance was
determined to be ∼10 MΩ. When the gap was 20 nm, the estimated resistance was ∼1.5 GΩ.
The conclusion of these experiments was that the space between the cell membrane and the
chip surface which was filled with cell medium, created a conductive sheet that prevented an
effective interaction by direct electrical polarization. The resistance that exists in this gap is
often referred to as the seal resistance (Rseal). One of the most important challenges in MEA
recording is increasing the value of this seal resistance.
To enhance the signal-to-noise ratio when recording with MEAs, attempts have been made to
hold or guide the cells. For example, if the cell can be positioned precisely on top of the sensor,
the distance between the cell and the sensor surface can be decreased. Lind et al. proved this
after performing a finite element analysis model of the extracellular action potential, whereby
cells surrounded by extracellular fluid were compared with cells in grooves and cubic pits.
The signal could be improved by as much as 700% when the extracellular space was confined
by the external structures (Lind et al. (1991)). These modeling results were later confirmed by
recordings of neurons from the snail Lymnaea stagnalis, cultured in a 10 µm wide, 1 µm deep
groove (Breckenridge et al. (1995)).
In the Bioelectronic Systems Group of the Interuniversity Micro-Electronics Center (IMEC) in
Leuven, Belgium, a multidisciplinary research team works towards the fabrication of micro-
structured electrode arrays with three-dimensional electrodes. The concept lays in the fact
that if the electrodes are small enough, the cell membrane will engulf the electrodes, creating
a strong interaction between the membrane and the electrode surface. This would eventu-
ally lead to a stronger electrical coupling because of a higher electrical resistance in the gap
between cell and chip. Preliminary data suggest strong engulfment of the electrode by the
cell membrane, as could be observed by immunohistochemical actin filament staining and
focused ion beam scanning electron microscopy (Figure 1)(Braeken et al. (2008); Huys et al.
(2008); Van Meerbergen et al. (2008)). Moreover, the electrodes are spaced very close to each
other, which allows for single cell recording and stimulation. However, this feature is highly
dependent on the technology level that is used.
2. Methods for Recording of Electrical Activity from Cells In Vivo
2.1 Introduction
Understanding of the neural codes and the development of brain-computer interfaces for the
normal and injured nervous system would require simultaneous selective recording and stim-
ulation at multiple locations along the sensory-motor circuits. At present, there are several
technological platforms that are capable of scaling to such recording and stimulation modali-
ties.
The probes designed for deep brain recording need to penetrate the soft meninges and the
underlying brain matter. Therefore, most of the designs implement either sharp tips or spe-
cialized add-ons for insertion. On the other hand, probes for surface recording, such as the
surface arrays and the cuff electrodes, are flexible and are designed to adapt to the surface of
the brain sulci or the nerves, respectively.
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Fig. 1. Micro-structured electrode arrays developed in IMEC, Belgium. a) Focused ion beam
scanning micrograph of a neuroblastoma cell on a nail bed. b) Actin filament staining of a
single cardiomyocyte on a nail bed. Scale bar is 3 µm. ©IMEC. All rights reserved.
2.2 Silicone-based Probes
The first silicon-based electrode arrays for ‘in vivo’ recording were developed by Wise, Starr,
and Angell in 1970 (Wise & Angell (1975); Wise et al. (1970)). They introduced the use of
integrated circuit (IC) technology to develop micro-electrodes.
2.2.1 The Michigan probe
BeMent et al. (1986) reported for the first time the development of a micro-fabricated micro-
electrode array from silicon having many recording contacts. These probes have evolved into
the devices commonly known as the Michigan probes. Michigan probes are supported and
distributed by the Center for Neural Communication Technology (CNCT) since 1994. There
are multiple designs already disseminated through CNCT. Some of them are commercially
available from the company NeuroNexus Technology.
The Michigan probes are based on a silicon substrate, the thickness and shape of which are
precisely defined using boron etch-stop micro-machining. The substrate supports an array of
conductors that are insulated by thin-film dielectrics. Openings through the upper dielectrics
are inlaid with metal to form the electrode sites for contact with the tissue, and the bond pads
for connection to the external world. The Michigan probe has also been modified for 3D con-
figuration. Arrays of planar, comb-like multi-shank structures have been assembled into 3D
arrays. Such three-dimensional structures can be constructed from the two-dimensional com-
ponents using micro-assembly techniques. The procedure is based on inserting multiple two-
dimensional probes into a silicon micro-machined platform that is intended to lay on the cor-
tical surface. The Michigan probe process is compatible with the inclusion of on-chip CMOS
(complementary metal-oxide semiconductor) circuitry for signal conditioning and multiplex-
ing. Such active arrays were also validated in neural recording experiments. Bai & Wise (2001)
reported the fabrication of "active" electrodes with monolithically integrated CMOS circuitry.
High density probes for massively parallel recording, with on-chip preamplifiers to remove
movement-related artifacts and reduce the weight of the headgear for small animals, were
used to record simultaneously from the soma and dendrites of the same neurons (Csicsvari
et al. (2003)).
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2.2.2 The Utah Electrode Array
The group of Dr. Richard Normann at the University of Utah, USA, developed a micro-
electrode array referred to as the Utah Electrode Array. The Utah Array has a matrix of
densely-packed penetrating shafts, which are between 1 and 1.5 mm long and project from
a very thin (200 µm) glass/silicon composite substrate and are separated from each other by
400 µm. The device is formed from a monocrystalline block of silicon using a diamond dicing
saw and chemical sharpening (Nordhausen et al. (1996)). It provides a multichannel interface
with the cortex. The resulting silicon shafts are electrically isolated from one another with a
glass frit and from the surrounding tissue with deposited polyimide or silicon nitride. The
tip-most 50 to 100 µm of each shaft is coated with platinum to form the recording contact. In-
terconnection to the electrode sites is accomplished by bonding either individual, insulated 25
µm-thick wires or a polyimide ribbon cable having many individual leads to bond pads on the
top of the array. The Utah array was originally designed with the goal to serve as an interface
for a human cortical visual prosthesis (Branner & Normann (2000)). Performed experiments
demonstrated numerous issues in favor of such an approach. Nevertheless, the device turned
to be a successful research tool in animal experimentation. For example, it was used for acute
and chronic recordings in the cat cortex (Maynard et al. (1997); Rousche & Normann (1998)).
A modified design was also tested in cat peripheral nerve (Branner & Normann (2000); Bran-
ner et al. (2001)). The design of the Utah array was used for human motor cortical prosthesis
spun-off in the company Cyberkinetics. There is an ongoing clinical trial authorized by FDA
in five severely disabled patients to determine the usability of the technology (Hochberg et al.
(2006)).
2.3 European designs
In Europe, there are co-ordinated efforts to build integrated probes for recording, stimulation
and local drug delivery. Among the leading centers are IMTEK in Germany, Twente Univer-
sity in the Netherlands, IMEC in Belgium and EPFL in Switzerland. The devices are based on
silicon micro-technology and are compatible with a CMOS process.
Several types of multi-electrode probes have been recently designed and fabricated at IMEC.
Musa et al. (2008) reported the fabrication of single-shank passive probes for cortical record-
ing. The probe implements a planar array of electrode contacts of varying sizes (4, 10, 25
and 50 µm). In some configurations, an additional larger reference electrode is placed close
to the electrode array. Another probe design contains crescent-shaped electrodes. Two of the
configurations are shown in Figure 2.
The devices produced in collaboration by IMTEK and IMEC1 are based on the principle of
modular assembly. The probes consist of needle-like structures made of silicon realized using
deep reactive ion etching (Ruther et al. (2008)). The first generation devices come as single-
shaft probes available in two lengths: 4 mm and 8 mm, each with cross-sections of 120 x 100
µm. In both cases, the probes have a row of nine equidistantly spaced, planar electrodes. The
second generation of devices comprises comb-like rows of four probes, each of them with the
same dimensions and number of electrodes as in the first generation. This two-dimensional
array can be provided with a guide wire or with a thumbtack structure for insertion purposes.
Another version of the device contains two such rows assembled in a back-to-back fashion.
Norlin et al. (2002) demonstrated the manufacture of a probe with 32 recording sites2. The
silicon probes consist of 8 shafts with a minimal cross-section of 20 µm x 20 µm. The shafts
1 part of the Neuroprobes research consortium
2 part of the VSAMUEL research consortium
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Fig. 2. First generation IMEC recording and stimulation probes
A – NP50 configuration. The probe contains 10 disk electrode sites arranged in a square lattice
with diameters of 50 µm. The spacing between contacts is 100 µm. The tip angle is 90◦. B –
NP25 configuration. The probe contains a linear array of 10 disk electrode sites with diameters
of 25 µm. The spacing between contacts is 50 µm. The tip angle is 90◦. The shafts are long 2
mm; the cross-section is 200 x 200 µm. The active interface is realized from Pt. The probes are
insulated with Parylene C. The fabrication approach is fully scalable. The fabrication process
can be easily adapted to produce longer probes. Scale bars are 100 µm. ©IMEC. All rights
reserved.
taper to very sharp tips (4◦). Each of the shafts carries four Ir micro-electrodes (10 µm x 10
µm) as recording sites on their side.
Rutten et al. (1995) reported the fabrication of a 3D needle array with 128 recording sites
on one electrode placed on the tip of a needle intended to serve as interface to peripheral
nerves. The different lengths of the needles allowed selective stimulation of different volumes
in peripheral nerves.
2.4 Non silicon-based hard substrates
Silicon-on-Insulator SOI electrodes can be also produced using silicon-on-insulator (SOI)
technology (Cheung (2007)). SOI wafers use an insulating oxide layer to separate a
thin silicon device layer (1 to 100 µm) from the thick silicon of the backside (about 500
µm thick). The SOI wafer gives excellent control over the final probe thickness. The
buried oxide acts as an etch stop during a backside deep RIE of the silicon wafer. The
same group presented SOI-based probes with integrated microfluidic channels, which
permitted localized injections of chemical substances of very small volumes.
Ceramic-based The insulator ceramic (alumina, Al2O3) has been used as a substrate to reduce
crosstalk between adjacent connecting lines (Burmeister & Gerhardt (2001); Burmeister
et al. (2000)). Ceramic is a mechanically strong material which allows for development
of micro-electrodes that can access much deeper brain structures (up to 5 – 6 cm versus
2 – 4 mm for silicon). Precise placement of the micro-electrode in tissue without flexing
or breaking can be achieved. Individual devices have to be cut from the wafer either by
a diamond saw or by a laser. Numerous four- and five-site platinum micro-electrodes
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on ceramic substrates have been developed. Some designs are used for electrochemical
measurements of neurotransmitters (Barbosa et al. (2008); Pomerleau et al. (2003)).
One of the very attractive features of the planar photo-engraved probes is the ability to cus-
tomize design for specific experiments. The substrate can have any two-dimensional shape
with single or multiple shanks, electrode sites can be of any surface area and can be placed
anywhere along the shank(s) at any spacing, tips can be made very sharp or blunt, and fea-
tures such as holes or channels can also be included.
2.5 Flexible substrates
The fabrication processes of flexible probes so far employed polyimide, parylene (DuPont)
and benzocyclobutene as substrate materials. Polyimide films have been also used as top
insulators for cortical micro-electrodes. Micro-electrodes less than 20 µm thick have been
constructed with the use of parylene (Rousche et al. (2001)).
Polyimide probes have also been seeded with bioactive molecules such as neural growth fac-
tor (NGF) near the recording sites (Rousche et al. (2001)) with the idea to encourage neurite
growth toward the active interface and to improve the stability in time (Metz et al. (2001)).
Benzocyclobutene can be used as an alternative to polyimide in the fabrication of neural in-
terfaces. For example, Lee, He & Wang (2004) reported the fabrication of benzocyclobutene
coated neural implants with embedded microfluidic channels (Lee, He & Wang (2004); Lee,
Clement, Massia & Kim (2004)).
An important development direction in Europe is the development of flexible electrodes for
cortical (Myllymaa et al. (2009); Rubehn et al. (2009)) and peripheral nerve recording (Navarro
et al. (2001); Stieglitz & Meyer (1999)). Developed electrodes have been based on polyimide
as carrier material.
Polymer-based implants using polyimide as both the structural and insulation material have
been micro-machined with multilayer metallization for both acute and chronic nerve record-
ing. Hybrid polyimide cuff electrodes embedded in silicone guidance channels have been
fabricated for electrical stimulation of peripheral nerves (Stieglitz et al. (2005)). Polyimide
sieve electrodes have been used in the regeneration and functional re-innervation of sensory
and motor nerve fibers (Rodríguez et al. (2000)).
Rubehn et al. (2009) reported the fabrication of a micro-machined 252-channel ECoG
(electrocorticogram)-electrode array made of a thin polyimide foil substrate enclosing sput-
tered platinum electrode sites and conductor paths. The array was designed to chronically
interface the visual cortex of the macaque.
3. Commercialized Micro-electrode Arrays
Only recently, micro-electrode arrays are being increasingly used. However, valuable research
was performed much earlier. The reason for earlier commercialization were the limitations of
the computing technology available at that time. Because of their recent accessibility and
affordability, interest in MEA systems has been renewed. Indeed, multi-electrode recordings
accelerate the collection of sample sizes needed for valuable statistical analyses in drug screen-
ing assays. Today, MEAs suitable for routine electrophysiological recordings to monitor the
activity of neuronal and cardiac populations in vitro are commercially available. Well-known
manufacturers of these systems include Multichannel Systems, AlphaMed, Ayanda Biosys-
tems and BioCell-Interface.
Most of the clinical neuronal probes used at present are fabricated by Medtronic. The Michi-
gan probe was commercialized in the company NeuroNexus Technology.
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4. Biomedical Applications of Micro-fabricated Arrays
4.1 Planar Micro-Electrode Array Systems
Micro-electrode arrays are fastly gaining interest as research instruments for the investiga-
tion of various disorders and diseases or the study of fundamental communication processes.
Because they do not require highly trained personnel, various tissue preparations can be ap-
plied to the electrode surfaces, including acute slices of brain, retina and heart and primary
dissociated cell cultures of different regions of the heart and central nervous system.
The biomedical applications are related to these preparations and can be classified into
two categories: neuronal and cardiac. Neuronal electrophysiological research with micro-
electrode arrays is conducted in various domains of neuroscience, for example long term po-
tentiation from acute slice preparations (Dimoka, Courellis, Gholmieh, Marmarelis & Berger
(2008); Dimoka, Courellis, Marmarelis & Berger (2008)) or organotypic slice cultures (Cater
et al. (2007); Haustein et al. (2008)), electroretinograms (Wilms & Eckhorn (2005)) and mi-
croERGs (Rosolen et al. (2008; 2002)) and recordings from cortical, hippocampal or striatal pri-
mary cell cultures for various studies including network plasticity (Chiappalone et al. (2008);
Wagenaar et al. (2006)) and memory processing and network activity (Baruchi & Ben-Jacob
(2007); Pasquale et al. (2008)). Micro-electrode arrays are also widely used to study electro-
physiological properties of the heart, such as gap junction functionality and impulse conduc-
tion (Reisner et al. (2008)), arrhythmias (Ocorr et al. (2007)) and experimental stem-cell derived
cardiac research (Gepstein (2008); Mauritz et al. (2008)).
4.2 Neuroprosthetic and Neuromodulatory Applications
4.2.1 Development of Neuroprosthetic applications
The development of neural prostheses was influenced to a great extent by the successful clin-
ical application of the cardiac pacemakers (review in Prodanov et al. (2003)).
In the 1970s, after two decades of continuous technological development, the pacemakers
were adopted on a great scale in clinical practice. Similar was the case of the respiratory
pacemakers, which were developed in parallel for patients suffered from cervical spinal cord
injury. Stimulation of the phrenic nerves causes constriction of the diaphragm and inspira-
tion. The first attempts to pace the diaphragm with implanted electrodes were carried out
in 1948 – 1950 by Sarnoff et al. (1950). One of the most important prerequisites for the clin-
ical acceptance of this technique was the introduction of the long-term electrical stimulation
by the radio-frequency inductive method around the end of the 1950s (Glenn et al. (1964)).
The first commercial phrenic nerve pacers were introduced in the early 1980s. Restoration of
hearing was successfully introduced in the late 1950s based on the previous observations of
Gersuni & Volokhov (1937). The proof of principle was demonstrated in the intraoperative ex-
periments of Djourno & Eyries (1957) who stimulated the inner ear by an implanted electrode
coupled inductively to an outside coil that was in turn connected to a microphone. The actual
usefulness of the first experimental device was very limited since the patient could recognize
only few words from the transmitted signal (papa, maman, and allo). The indications and con-
traindications for this implantation were elaborated in a broad debate between the clinicians
and the pioneers of the cochlear prostheses. The general approval of the cochlear prostheses
was given by FDA in 1984 after 20 years of design and trials. Over the past 20 years of clinical
experience, more than 20 000 people worldwide have received cochlear implants. Cochlear
implantation has a profound impact on hearing and speech perception in postlingually deaf-
ened adults. Most individuals demonstrate significantly enhanced speech reading capabilities
during daily life. To restore the lost functions of the paralyzed leg muscles, experiments were
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performed for the first time in 1961 by Liberson et al. (1961). The system was developed to
compensate for the "drop foot" problem in hemiplegic stroke patients. The "drop foot" stimu-
lation systems activate the nerve fibers in the peroneal nerve with the net effect of flexion in
the tarsal joint.
From the presented cases, it is apparent that the successfully applied neural prostheses so-far
have been developed for systems, which have either uniform topographic mapping, such as
the phrenic or peroneal nerves, and/or inherent ability to learn the stimulation pattern - for
example the auditory prostheses.
In contrast, in other sensory and motor systems so-derived principles apply to a limited ex-
tent and the performance of the neural prostheses is lower. For example, the usefulness of the
motor neural prostheses is still insufficient for general clinical use. Motor tasks require orches-
trated activation of many muscles, which in turn requires selective stimulation of only defined
parts of the nerves or muscle groups. Existing leg and hand neuroprostheses are still far from
providing such level of functional selectivity without extensive surgery. Steps towards im-
proving the expected selectivity of stimulation were made by investigation of the topographic
mapping of some peripheral nerves and spinal roots in rats (Prodanov (2006); Prodanov &
Feirabend (2007; 2008); Prodanov et al. (2007)). However, those results still need to be trans-
lated to men. Other examples are some of the hand prostheses and orthoses. Most of the
proposed implantable systems require extensive surgery in order to interface the hand nerves
at several locations to improve selectivity. The surface stimulation systems need to combine
several stimulation channels to provide an acceptable level of selectivity. The neuroprostheses
have demonstrated improvement of the grasping function in clinical trials including stroke or
spinal cord injury subjects. However, the grasp strategies that can be provided with the exist-
ing neuroprostheses for grasping are very limited and can only be used for a restricted set of
grasping and holding tasks (review in Prodanov et al. (2003)).
Visual prostheses have been developed for the last 30 years (review in Prodanov et al. (2003)).
Major research lines were focused on the development of cortical prostheses (Brindley &
Lewin, 1968; Dobelle & Mladejovsky, 1974; Normann et al., 2001); retinal prostheses (review
in Zrenner (2002)) and optic nerve prostheses (Veraart et al. (1998)). The results in the field
demonstrate that generating perception of light patterns in blind people is feasible. However,
true object recognition still can not be achieved. The surface cortical microstimulation (Brindley
& Lewin (1968); Dobelle & Mladejovsky (1974)) could not provide useful images because of
its limited spatial resolution and the fading of the induced phosphenes (sensations of light).
Subsequent human trials with penetrating cortical implants (i.e. Utah arrays; see section 2.2.2)
were more promising (Dobelle (2000); Normann et al. (1996); Schmidt et al. (1996)), but dimin-
ished neuronal excitation and the stability of spatial resolution were still unsolved problems
even using high-resolution intracortical electrode arrays (Normann et al. (2001)). The group of
Veraart at Université Catholique Louvain (UCL), Brussels, demonstrated that by stimulation
of the optic nerve to have the patient recognize single spots of light (Veraart et al. (1998)).
In the end of the 1980s, several North American, Australian and European teams (Eckmiller
(1997)) started developing retinal prostheses. Notably, these are the groups of M. Humayun
(John Hopkins University) (Schmidt et al. (1996)) and that of J. Rizzo (Harvard University)
(Rizzo et al. (2003)) in association with the Massachusetts Institute of Technology, which de-
velop epiretinal implants. The epiretinal implant has no light-sensitive elements. In the
epiretinal configuration a tiny camera-like sensor is positioned either outside the eye or within
an intraocular plastic lens that replaces the natural lens of the eye. An alternative type of reti-
nal prosthesis is the subretinal implant developed by Chow & Chow (1997) in Chicago and
www.intechopen.com
	
	
	
	
		

  
Zrenner et al. (1997) in Tübingen. The Tübingen subretinal device is implanted between the
pigment epithelial layer and the outer layer of the retina. The device consists of thousands
of light-sensitive microphotodiodes equipped with micro-electrodes assembled on a very thin
plate. The light falling on the retina generates currents in the photodiodes, which then activate
the micro-electrodes and stimulate the retinal sensory neurons. Epiretinal and subretinal im-
plants depend on the uniform topographic mapping of the retina. If the provided stimulation
can trigger learning phenomena in the visual system, we could anticipate another successful
clinical application.
4.2.2 Development of Neuromodulatory applications
Deep brain stimulation (DBS) and vagus nerve stimulation (VNS) can be regarded as examples
for fast-developing neuromodulatory applications. DBS will be used further also to illustrate
some of the challenges in the development of neural interfaces with the brain.
VNS uses an implanted battery-powered signal generator, which stimulates the left vagus
nerve in the neck via a pair of spiral cuff-electrodes connected through a lead wire also im-
planted under the skin. In the case of VNS, the first experimental demonstrations of an anti-
convulsant effect of VNS were made in 1980s (reviews in George et al. (2000) and Groves &
Brown (2005)). So far the FDA approved the use of VNS as an adjunctive therapy for epilepsy
in 1997 and for treatment resistent depression in 2005. Ongoing experimental investigations
include various anxiety disorders, Alzheimer’s disease, migraines (Groves & Brown (2005)),
and fibromyalgia. Current implantable systems (notably the NCP system of Cyberonics Ltd)
provide non-selective stimulation, which activates all Aα nerve fibers. Since the vagus nerve
projects to three major brain stem nuclei 3, which in turn relay to other brain stem nuclei, such
as the reticular formation, the parabrachial nucleus and the locus coeruleus, the effects in-
duced by the electric stimulation of the vagus Aα nerve fibers are multiple and most probably
interact with each other. Therefore, the beneficial effects of VNS most probably develop by
plastic changes in all affected subsystems, i.e. a learning phenomenon.
Deep brain stimulation is a surgical treatment involving the implantation of electrodes in the
brain, which are driven through a battery-powered programmable stimulator. Current ver-
sions of the therapy use high-frequency stimulation trains (i.e. in the range 80 – 130 Hz),
which can modulate certain parts of the the motor circuits in the basal ganglia.
In 1991, two groups independently reported beneficial effects of thalamic stimulation for
tremor suppression (Benabid et al. (1991); Blond & Siegfried (1991)). DBS is considered al-
ready as a standard and accepted treatment for Parkinson’s disease (Deep Brain Stimulation
in Parkinson’s Disease Group, 2001), essential tremor, dystonia, and cerebellar outflow tremor
(recent overview in Baind et al. (2009)). In the USA, the FDA approved DBS as a treatment for
essential tremor in 1997, for Parkinson’s disease in 2002 and for dystonia in 2003. There are
undergoing clinical trials for epilepsy, depression, obsessive-compulsive disorder, and mini-
mally conscious states (review in Montgomery & Gale (2008)). DBS offers important advan-
tages over the irreversible effects of ablative procedures, including the reversibility of the sur-
gical outcome and the ability to adjust stimulation parameters post-operatively to optimize
therapeutic benefit for the patient while minimizing adverse effects (Johnson et al. (2008)).
The mechanisms of action of DBS are still subject to debate arising from conflicting sets of ex-
perimental observations. Early hypotheses proposed that stimulation mimicked the outcome
of ablative surgeries by inhibiting neuronal activity at the site of stimulation, i.e. "functional
3 n. dorsalis n. vagi (efferent), n. tractus solitarii (afferent), n. ambiguus (afferent)
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ablation". This comprises the direct inhibition hypothesis. Several possibilities have been pro-
posed to explain this view including (i) depolarization blockade, (ii) synaptic inhibition, (iii)
neurotransmitter depression, and (iv) stimulation of presynaptic terminals with neurotrans-
mitter release (see McIntyre et al. (2004)). Recent studies have challenged this hypothesis (re-
views in Johnson et al. (2008); Montgomery & Gale (2008)), suggesting that, although somatic
activity near the DBS electrode may exhibit substantial inhibition or complex modulation pat-
terns, the output from the stimulated nucleus follows the DBS pulse train by direct axonal
excitation. The intrinsic activity is thus overridden by more regular high-frequency activity
that is induced by the stimulation. A number of alternative hypotheses about the mechanisms
of DBS are offered in literature (Montgomery & Gale (2008)). These include (i) indirect inhi-
bition of the stimulated nucleus possibly through thalamo-cortical loops; (ii) increased regu-
larity of globus pallidus internus firing by decrease of the information content of the network
output due to the regularity of the stimulation; and (iii) resonance effects through stimulation
via reentrant loops. None of proposed hypothesis is entirely supported by the existing exper-
imental evidence. However, in view of the recent experimental evidence, the direct inhibition
hypothesis seems least probable.
If the same considerations apply also for neuromodulation, two similar principles of devel-
opment can be stated. The successful neuromodulatory systems will be appplied in areas
with uniform or discrete topology (for example the vagus nerve) and the overall effect of the
applied stimulation should affect generic/systemic control mechanisms.
II. Biocompatibility of Micro-fabricated Devices
5. Introduction
When combining non-biological entity with living, biological matter, interaction between both
is inevitable. When interfacing biological elements, whether they are peptides, proteins, cells
or tissues, with non-biological elements, a new interface or situation is created. This interface
situation is an interaction between two completely different milieus and, therefore, it is a cru-
cial element for an optimal functioning of both. This interaction can either influence the role
of both the biological and non-biological element in a manner that can change the original
state of that element, and therefore, it can not be neglected. In this part, we will introduce the
interfacing problems that originate from the contact between biological samples and tissues
and non-biological materials present in implants and other bioelectronic devices. Biocompat-
ibility issues and challenges will be presented for both in vivo and in vitro conditions, and
future challenges and directions will be discussed.
Biocompatibility is extensively debated in biomaterials science and bioelectronic interfac-
ing, but its definition is questionable and very broad. Because many different situations in
biomedical engineering exist where biocompatibility is an issue, the uncertainty about the
mechanisms and conditions is a serious impediment to the development of new techniques in
biomedical and nanobiological research.
Biocompatibility refers to the ability of a material to perform with an appropriate host re-
sponse in a speficic situation. This definition states that a material as such can not just exist in-
side a tissue or close to a biological organism, but has to fulfill three major requirements: (i) the
response it evokes has to be appropriate for the application, (ii) the nature of the response to a
certain material and (iii) its appropriateness may vary from one situation to another (Williams
(1987; 2008a;b)). However, this definition is very general and so self-evident that it does not
lead to an advancing knowlegde of biocompatibility. It is more likely that one concept cannot
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apply to all material-biological element reactions in the widely spread applications such as
brain implants, tissue engineering, prosthesis, biosensors or micro-electrode arrays. The na-
ture of material itself plays a large role in the evoked response in the biological element. Some
major material variables are material composition, micro- (or nano)-structure, morphology,
hydrophobicity or hydrophilicity, porosity, surface chemical and topographical composition,
surface electronic properties, corrosition parameters and metal ion toxicity. These parameters
can all influence the functioning of the biological element (Williams (2008a)).
6. Biocompatibility of In Vitro Devices
6.1 Cytotoxicity
Although the degree of biocompatibility is much more complex at the level of implantable
materials and devices, in vitro biocompatibility cannot be neglected, especially because of
the growing amount of new materials and technologies. In the following, biocompatibility
will be described in the specific situation of micro-electrode arrays, a fast growing field in
bioelectronics. Micro-electrode arrays can consist of many different materials, for which some
general cytotoxicity is known, but for others, very little information is available.
Cytotoxicity is strongly dependent on the type of cell or cell culture that is used. A material
which is toxic for one type of cell is not necessarily toxic for another, or the lethal concentration
(LC50) can be vastly different. Therefore, a cytotoxicity test should always be designed for the
final situation were the system will be used. It is clear that immortalized cancer cell lines are
more robust to cytotoxic agents than fresh, primary cell preparations (e.g., Olschlager et al.
(2009)). It is, therefore, important that the biocompatibility test is carefully designed. For ob-
vious reasons, cell cultures of excitable cells are interesting for cultivation on micro-electrode
arrays. These cell cultures mostly include preparations of the heart (embryonic artrial, ventric-
ular or whole heart cultures) and the central nervous system (embryonic cortical, hippocam-
pal, spinal cord cultures) and retinal neuronal cultures. Viability assays for these cell cultures
include visual microscopic inspection, trypan blue staining, cell death (apoptosis and necro-
sis) assays using fluorescent microscopy, bioluminescence imaging and cytofluorometry. At
present, there is a variety of standardized ready-to-use assays available to investigate cell pro-
liferation, adhesion and survival.
copper toxicity Materials used in modern micro-fabrication are typically chosen based on
their durability, ease of processing, conductivity and price. However, this mostly ap-
pears to be at odds with their biocompatible properties. Although most commercialized
micro-electrode arrays are fabricated with biocompatible materials including borosili-
cate glass, platinum, gold, titanium (nitride), and several metal oxides, more advanced
technologies require unexplored materials. One of the most important materials used
in advanced complementary metal oxide semiconductor (CMOS) technology is copper.
Copper is a cheap material with excellent conducting properties which is relatively easy
to process in micro-fabrication tools.
Because copper can migrate fast through other materials, it can cause problems in bio-
electronic devices. Copper (Cu) is an essential trace element found in small amounts in a
variety of cells and tissues with the highest concentrations in the liver. Cu ions can exist
in both an oxidized, cupric (Cu2+), or reduced, cuprous (Cu+), state. Copper functions
as a co-factor and is required for structural and catalytic properties of a variety of im-
portant enzymes, including cytochrome c oxidase, tyrosinase, and Cu-Zn superoxidase
dismutase. Copper is known to be a highly cytotoxic material. Several reports show the
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role of reactive oxygen species (ROS) in cell death induced by heavy metals (Houghton
& Nicholas (2009)). Both cupric and cuprous ions can participate in oxidation and re-
duction reactions. In the presence of superoxide or reducing agents such as ascorbic
acid, Cu2+ can be reduced to Cu+, which is capable of catalyzing the formation of
hydroxyl radicals from hydrogen peroxide. This is called the Haber-Weiss reaction,
whereby copper catalyzes the formation of ROS by peroxidation of membranous lipids.
The hydroxyl radical is the most powerful oxidizing radical likely to arise in biological
systems, and is capable of reacting with practically every biological molecule (Buettner
& Oberley (1979)). It can initiate oxidative damage by abstracting the hydrogen from
an amino-bearing carbon to form a carbon-centered protein radical and from an un-
saturated fatty acid to form a lipid radical (Powell et al. (1999)). Copper is cabable of
inducing DNA strand breaks and oxidation of bases (Kawanishi et al. (2002)).
6.2 Interface Layers for Cell-based Biosensors
Another important aspect of in vitro biocompatibility is the growth of cell cultures on top of
electrode surfaces. To perform successful experiments with cells on micro-electrode arrays,
cells must adhere, grow and maintain on the surface of electrodes. Although some cells, such
as immortalized fibroblast cell lines, can adhere easily to most surfaces, most cells need an
interface layer to be present to adhere. The following describes straightforward methods for
the adhesion and growth of various cell cultures.
An interface layer must mimic the normal environment of the biological element, creating
optimal conditions for optimal functioning of the hybrid device. Although there are various
strategies to construct interface layers, not all of them are suitable for cell-based biosensor
technology. Self-assembled monolayers (SAMs) offer a reproducible manner of interfacing
cells with sensor materials. Extracellular matrix peptides, polymers or proteins are also often
used to attract and adhere cells. The enhancement of cell attachment and spreading through
surface functionalization is a crucial parameter in the optimalization of the functioning of
cell-based micro-electrode arrays.
6.2.1 Self-Assmbled Monolayers
Characterized by high temperatures and the formation of a monolayer, chemisorption is often
used in the formation of SAMs. They provide a convenient, flexible and simple system that
tailors the interfacial properties of metals, metal oxides and semiconductors. Self-assembled
monolayers are organic assemblies formed by the adsorption of molecular constituents de-
posited from solution or vapor onto a solid surface. They organize spontaneously into crys-
talline structures. However, the experimental conditions for their development need to be
strictly controlled to ensure clean, complete monolayer formation. The molecules that form
SAMs have a chemical functionality, or ‘headgroup’, with a specific affinity for a substrate.
In many cases, the headgroup also has a high affinity for the surface and displaces other ad-
sorbed organic materials (Love et al. (2005)). The headgroup-substrate pair is typically used
to define the individual SAM system. The most common examples are thiols (R-SH, where
R denotes the rest of the molecule) on metals (e.g., gold, platinum) or silane-based molecules
on metal/semiconductor oxides (e.g., silicon dioxide, tantalum pentoxide). Self-assembled
monolayers are structurally well-ordered, and are therefore an ideal substrate for the bind-
ing of various extracellular matrix proteins. The proteins adsorbed on top of these layers can
be structured and immobilized with a large density to promote attachment, spreading and
migration of cells.
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Self-assembled monolayers can be also engineered to prevent non-specific adsorption of pro-
teins (Frederix et al. (2004)). The majority of applications that have been reported make use
of polyethylene glycol or derivates, which excludes protein adsorption through mechanisms
that depend on the conformational properties of highly solvated polymer layers. Another
approach of SAMs for the adhesion of cells is the use of monolayers that present peptide frag-
ments from extracellular proteins such as fibronectin. These peptides are ligands for some of
the integrin family cell-surface receptors, which are an important class of receptors found on
all cellular surfaces and that mediate attachment of cells to the extracellular matrix (Critch-
ley (2000)). Many different peptides fragments have been used over the years to promote
cell adhesion to electrode surfaces or chip surfaces (Huang et al. (2009); Tsai et al. (2009);
Van Meerbergen et al. (2008)).
6.2.2 Extracellular Matrix Proteins and Polymers
Extracellular matrix proteins that are often used for cell adhesion are laminin, fibronectin, and
collagen. These proteins directly bind to integrin receptors on the outside of the cell mem-
brane (Critchley (2000)). In this way, they communicate in a direct way with the cytoskeleton
of the cell, responsible for cell adhesion and spreading on surfaces. Although not inherently
biological, many polymers have been used as well to promote cell adhesion, including poly-
L/D-lysine, poly-L-ornithine and polyethyleneimine. The principle of cell adhesion using
these artificial ligands is based upon the strong electrostatic binding of the cell membrane to
the surface (Hategan et al. (2004)). The main advantage and the direct reason of their success
is the availability and price of these synthetic molecules.
7. Biocompatibility of Implantable Devices
7.1 Regulatory Aspects
The selection and evaluation of materials and devices intended for use in humans requires
a structured program of assessment to establish appropriate levels of biocompatibility and
safety. Current regulations, whether in accordance with the US FDA (ISO 10993-1/EN 30993
standard, since 1995), the International Organization for Standardization (ISO), or EU regula-
tion bodies (The EU Council Directive - 93/42/EEC), as part of the regulatory clearance pro-
cess require conduction of adequate safety testing of the finished devices through pre-clinical
and clinical phases (Bollen & Svendsen (1997)). An extensive account on the biocompatibility
can be found in the standard ISO 10993-1/EN 30993. An implant can be considered biocom-
patible if it gives negative results on the following tests:
cytotoxicity The aim of in vitro cytotoxicity tests is to detect the potential ability of a device
to induce sublethal or lethal effects on mammal cells (mostly on fibroblast cultures).
Three main types of cell-culture assays have been developed: the elution test, the direct-
contact test, and the agar diffusion test.
sensitisation The sensitization test recognizes a possible sensitization reaction (allergic con-
tact dermatitis) induced by a device, and is required by the ISO 10993-1 standard for all
device categories.
genotoxicity Genetic toxicity tests are used to investigate materials for possible mutagenic
effects–that is, damage to the genes or chromosomes of the test organism (e.g. bacteria
or mammal cells).
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implantation Implantation tests are designed to assess any localized effects of a device de-
signed to be used inside the human body. Implantation testing methods essentially
attempt to imitate the intended conditions of use.
carcinogenicity The objective of long-term carcinogenicity studies is to observe test animals
over a major portion of their life span to detect any development of neoplastic lesions
(tumor induction) during or after exposure to various doses of a test substance.
skin irritation The ISO 10993-10 standard describes skin-irritation tests for both single and
cumulative exposure to a device. Skin-irritation tests of medical devices are performed
either with two extracts obtained with polar and nonpolar solvents or with the device
itself.
intracutaneous reactivity The intracutaneous reactivity test is designed to assess the local-
ized reaction of tissue to the presence of a given substance.
acute systemic toxicity is the adverse effect occurring within a short time after administra-
tion of a single dose of to the presence of given substances. ISO 10993-1 requires that
the test for acute systemic toxicity be considered for all device categories that indicate
blood contact. For this test, extracts of medical devices are usually administered intra-
venously or intraperitoneally in rabbits or mice.
subchronic and chronic toxicity tests are carried out after initial information on toxicity has
been obtained by acute testing, and provides data on possible health hazards likely to
arise from repeated exposures over a limited time.
As can be seen from Figure 4, undesirable interactions affecting biocompatibility can occur in
most of the levels of the issue tree. For example, implants may be subject to continuous attacks
by hydrolytic enzymes or free radicals produced by macrophages and/or cell lysis (Salthouse
(1976)). Stability of implanted material is important not only for a stable function but also
because degradation products may be harmful to the host organism. An overview on the
biological reactions to implanted materials can be found in Ratner et al. (1996).
While the ISO standard addresses the general bio-compatibilty requirements of a medical de-
vice, it does not address specifically the interactions on the active tissue-device interface.
7.2 Interactions on the Active Interface
7.2.1 Chemical Properties of the Active Interface
Appropriate implant materials should be as chemically inert as possible. If chemical reactions
are to be expected, they should be minimal and all resulting products should be inert. Can-
didate materials for use in neuroprotheses pass very rigorous testing since they must remain
inert not only passively but also when subjected to electrical stimulation and when placed in
contact with the biological tissue.
According to the literature the following criteria should be considered when choosing material
for an implanted electrode: (i) the intensity of the tissue response, (ii) eventual occurrence
of allergic response, (iii) electrode-tissue impedance, (iv) radiographic visibility and (v) MRI
safety (Geddes & Roeder (2003)).
For electrodes that make Ohmic contact with tissues, Au, Pt, Pt-Ir alloys, W, and Ta are recom-
mended as materials for the active interface (Geddes & Roeder (2003); Heiduschka & Thanos
(1998)). The use of some metals should be avoided because of vigorous tissue reactivity. These
pure metals are notably Fe, Cu, Ag, Co, Zn, Mg, Mn, and Al (Geddes & Roeder (2003)).
It can be necessary to distinguish between stimulating and recording electrodes. Good mate-
rials for recording electrodes are: Pt, Ir, and Rh and Au. Materials of choice for stimulating
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Fig. 3. Loss of signal
The immediate effects are caused by the mechanical interaction of the device with the brain tissue during
implantation. These are notably vascular damage, hemorrhage and brain edema.
During the progressive phase, the acute inflammation, cell death and nerve fiber degeneration predom-
inate. The inflammation process is driven by the complement complex activation, the extravasation of
neutrophils and mononuclear cells and the secretion of cytokines. The late effects involve gliosis or
chronic inflammation and the tissue remodeling. Some processes, notably the micromotion and mechan-
ical strain, act continuously during all stages.
electrodes are Pt, Pt-Ir alloys, W, and Rh. For capacitive stimulating electrodes, tantalum
pentoxide (Ta2O5) has the highest dielectric constant, followed by iridium oxide (IrO2). Alu-
minum oxide (Al2O3) is a candidate with a lower dielectric constant.
Glassy carbon or carbon fibers are also used as electrode materials, and they are biocompatible
and stable, though they have a higher roughness than metals. Among the currently studied
conducting polymers, polypyrrole (PPy) and poly-3,4-ethylenedioxythiopentane (PEDOT) ap-
pear the best candidates for materials. They provide interesting opportunities to incorporate
other substances, for example peptides or growth factors, during the process of polymerisa-
tion in order to improve biocompatibility in vivo. Interesting candidates for materials are the
nano-structured materials and notably the carbon nanotubes.
7.2.2 Biotic-abiotic Reactions
As recognized by many groups in the field, one of the central issues in favor of a closed-loop
implantable system is the uncertain performance of the recording function in chronic condi-
tions (Berger et al. (2007)). This can be attributed to causes related to the device, to the tissue or
to the active interface (Figure 3). While it is generally believed that the brain tissue response to
chronically implanted silicon micro-electrode arrays contributes to recording instability and
failure, the underlying mechanisms are unclear. From the side of the tissue the loss of signal
can be caused by several biological processes, which are part of the response to implantation.
The loss of sources could occur due to neuronal cell death or spatial shift. Neuronal cell death
can occur early after implantation when some neurons close to the insertion track die due
to the trauma. At a later stage, some neurons can die due to the continuing process of neu-
roinflammation. It has been shown that activated macrophages migrate to the device-tissue
interface and suggested that the presence of such devices are a persistent source of inflam-
matory stimuli (i.e. classical "foreign body" reaction). Since macrophages can be a source of
neurotoxic cytokines, they could potentially induce cell death in the surrounding neurons.
The effect of the activated macrophages on the quality of electrophysiological recording is
still largely unexplored. In addition to the persistence of inflammatory cells, studies have
observed significant reductions in nerve fiber density and neuronal cell bodies in the tissue
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immediately surrounding implanted electrodes (Biran et al. (2005); Edell et al. (1992)). The
spatial shift can also occur in different times after implantation. Early after implantation, the
resorption of the local tissue edema can retract the tissue surrounding the active interface.
This could result in liquid pocket, which can serve as a shunt for the neuronal signal.
At a later stage, the neuroinflammatory events lead to the formation of dense mesh of astro-
cytes and extracellular matrix proteins, which form together the glial scar. The formation of
the glial scar (gliosis) is a complex reactive process involving the interaction between several
types of cells, notably astrocytes and activated microglia. During this process the cells change
substantially the composition, the morphology and the functional properties of the extracellu-
lar matrix. Detailed overviews of the process can be found in (Stichel & Müller (1998),Michael
et al. (2008) and Polikov et al. (2005)). These observations motivated hypotheses that astrogli-
otic encapsulation contributes to the failure of such devices to maintain connectivity with
adjacent neurons due to increase of the active interface impedance possibly by increase of the
diffusion path (Syková (2005)). This scar may serve as a spatial barrier (low pass filter) for
the neuronal signal. The hyperthrophy of the extracellular matrix could retract the remaining
neurons out of the optimal recording distance (Polikov et al. (2005)).
7.2.3 Nervous tissue reaction to electrical stimulation
Electrical stimulation of nervous tissue could result in neuronal excitation, metabolic changes
and/or cell damage. In general, low-intensity suprathreshold stimulation will result in exci-
tation and transient changes of the cell metabolism and gene expression. On the other hand,
prolonged and high-intensity electrical stimulation could result in cell damage and eventual
death.
Suprathreshold electric stimulation of the peripheral or the cranial nerves results in increased
expression of the so-called immediate early genes (IEG), such as c-fos, in the neuronal cell
bodies anatomically connected with the stimulated region (Liang & Jones (1996)). For exam-
ple, brief unilateral electrical stimulation of the cochlear nerve (120-250 µA, 5 Hz, 30 min)
in anaesthetized rats with a biphasic current resulted in increased expression of c-Fos in the
ipsilateral ventral and in the dorsal cochlear nuclei bilaterally (Nakamura et al. (2003)). Intra-
cochlear electrical stimulation using a cochlear implant led to changes in the phosphorylation
state of the cAMP response element binding protein (CREB) and the expression of c-Fos and
Egr-1 in the auditory brainstem nuclei in a tonotopical pattern (Illing et al. (2002)).
Electrical stimulation at high intensities results in damage of the nervous tissue. Analyzing
previous results of Agnew & McCreery (1990); McCreery et al. (1990; 1992); Shannon (1992)
presented an empirical model explaining the safety limits of electrical stimulation parame-
ters. However, the model gives little physical and physiological insight into the mechanisms
of damage. Butterwick et al. (2007) established that for electrodes having diameters larger
than the distance to target cells the current density determined the damage threshold and
small electrodes (diameters less than 200 µm ), acted as point sources and the total current
determined the damage threshold. The width of the safe therapeutic window (i.e., the ra-
tio of damage threshold to stimulation threshold) depended on pulse duration. The damage
threshold current density on large electrodes scaled with pulse duration as approximately
1/
√
Tpulse. The threshold current density for repeated exposure on the retina varied between
61 mA/cm2 at 6 ms to 1.3 A/cm2 at 6 µs.
The neuronal injury originating from electrical stimulation can occur by several mechanisms:
Electrochemical injury, which can result from the production of substances on the electrodes,
for example local changes in pH or diffusion of toxic ions into the electrolyte. Brummer
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& Turner (1972) have shown that the rate of production of compounds by electrochem-
ical reactions and the type of compounds produced are directly related to the charge
density4.
Cell injury resulting from electroporation A possible mechanism for electrical damage is
electroporation or electropermeabilization. Recently, Butterwick et al. (2007) claimed
that electroporation is the mechanism which underlines retinal damage during micro-
electrode stimulation. During electroporation, the applied pulses of electric field create
transient hydrophilic pores in the cell membrane of different sizes (Krassowska & Filev
(2007); Smith et al. (2004)) and different life times.
Excitotoxic neuronal injury, which is caused by the excitatory neurotransmitter glutamate
through its NMDA receptors. This view is supported also by the finding that the
NMDA receptor antagonist MK-801 (dizocilpine) is a neuroprotective factor during
prolonged electrical stimulation (Agnew et al. (1993)). The mechanism of the induced
neuronal cell death is necrotic.
III. Challenges and Issues in the Development of Micro-fabricated Devices
Issues in the development of neural prostheses are interrelated and frequently arise due to
contradicting feature requirements. For example, the perfect DBS system should provide stim-
ulation on-demand in order to maximize the lifetime of operation and minimize the amount
of transferred charge and the amount of cell damage (Section 7.2.3). This implies the presence
of recording functionality and software able to distinguish between normal and pathologi-
cal neuronal circuit activity in the relevant signal bands (e.g., action potentials and/or local
field potentials). Implementation of such software implies certain active signal processing
that should occur in the implant, which would lead to the increase of the power consumption.
Then the question would be whether such approach can actually increase the lifetime of the
battery. Such ideal device should also deliver highly selective electrical stimulation in order
to minimize the unwanted stimulation of other brain circuits. The electrode tissue interface
should be stable for the whole lifetime of the device (possibly several decades).
Micro-fabricated devices that can be used in vitro for the recording and stimulation from sin-
gle cells should on the one hand interfere minimally with the cells positioned on top of the
electrodes, but on the other hand, a good coupling between the cell and the chip is desired.
Although recent advances in micro-fabrication and computing technology have created many
opportunities, the challenges that we face in the development of such devices remain critical.
In the following, issues related to the development of both in vitro and in vivo systems are
highlighted, and some future directions and perspectives are suggested.
Issues in the development of implantable systems can be conceptualized in the diagram
shown in Figure 4. These can be conveniently classified as issues related to the active in-
terface, the overall device, the biological system and issues stemming from deficiencies in the
knowledge base. On the level of the active interface, there are several interrelated biophysi-
cal, chemical and biological processes that can result in changes of the electrical coupling of
the active interface. Such changes of the active interface are manifested by changes of the
electrical impedance and eventual loss of the neuronal signal. This is especially valid for the
implantable prostheses, but also true in in vitro systems.
The bio-physico-chemical interactions on the active interface can include release of metal ions
or molecules into the extracellular space (due to corrosion of the metal electrode surfaces or
4 the charge transferred per unit area of the electrode surface
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Fig. 4. Issues related to the development of micro-fabricated devices.
depolymerisation in case of polymeric electrodes) and biochemical reactions with the sur-
rounding cells and extracellular matrix. While the biophysical and chemical aspects of those
processes have been established, the biochemical and pathophysiogcial aspects are still un-
der investigation. Notably, our understanding of the evolution of the encapsulation process
(gliosis) and its influence on the recording capabilities and the eventual loss of signal, are
incomplete.
On the level of the biological system (e.g. the human body), it is important to note the aspects
of mechanical interactions, the side effects of stimulation and the overall biocompatibility. The
mechanical interactions between the device and the body and notably the micro-motions are
caused by the respiration and heartbeats and the strain of the leads that can be caused by di-
rected movements (e.g., by the head, neck, etc.). Other potential issues can be related to the
general biocompatibility of the device. This evolved into a set of regulatory requirements (sec-
tion 7). Some issues can be grouped around the undesired effects of the electrical stimulation,
e.g. excitation or inhibition of other neuronal circuits, which can lead to undesired physiolog-
ical and/or behavioral effects.
As discussed in section 7, direct cytotoxicity is an important factor in the development of
in vitro devices. Leakage of metal ions from materials used in devices and their diffusion
in the cell medium leads to toxicity problems. Materials used in innovative and advanced
technologies, therefore, need to be investigated on the cellular level before implementation.
Different from implantable devices, in vitro devices require sophisticated surface chemistries
that have to be characterized for specific materials and applications. Hence, cell adhesion and
growth is a key factor in these devices.
On the level of the knowledge base there are deficiencies in the understanding of the func-
tional organization of the brain, the detailed mapping of the anatomical connectivity and the
control signals. The control signals which are delivered through the active interface in many
www.intechopen.com
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types of neural prostheses are unclear. Notable exceptions for this are the auditory cochlear
prostheses, which exploit the sonotopic organization of the cochlea, the cardiac pacemakers,
the phrenic stimulator and the foot drop stimulator. Current DBS systems for Parkinson’s dis-
ease rely on the high frequency stimulation, which can result in blocking of certain mid-brain
pathways. The encoding of the kinematic information in these structures is still unknown.
Dissociated cell cultures lose their anatomical connectivity and structure when seeded on
substrates in vitro. The ‘new’ situation that exists on these surfaces is interesting in terms
of communication between individual cells and their function in advanced networks. How-
ever, the translation of these processes to the in vivo situation is not always straightforward
and challenging.
On the level of the overall device several types of issues can be grouped in the categories of
configuration and operation. Issues related to the configuration can be related to the assembly,
the size and topology of the device, the encapsulation and the packaging of the device. De-
vices have to be packaged in a way that prevents leakage of the environment, which contains
high salt and protein concentrations, to the chip. These packages have to be leakage-proof on
the one hand and non-toxic for the cell culture or tissue on the other hand.
Issues related to the operation of the device can be grouped under the power, safety and
communication of the device. The operation has to be compatible with cell cultures or in
vivo environments, which in this case has to be in agreement with certain regulations. One
other important aspect of the safety of operation are the interactions with other equipment,
for example MRI.
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